Paradigm BioCapital Advisors LP 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:42 pm Sale |
2024-12-31 | 13G | Kura Oncology, Inc. KURA |
Paradigm BioCapital Advisors LP | 0 0.000% |
-4,331,321 (Position Closed) |
Filing |
| 2024-11-14 4:31 pm Purchase |
2024-09-30 | 13G | Kura Oncology, Inc. KURA |
Paradigm BioCapital Advisors LP | 4,331,321 5.700% |
470,003 (+12.17%) |
Filing |
| 2024-05-02 4:34 pm Purchase |
2024-04-22 | 13G | Kura Oncology, Inc. KURA |
Paradigm BioCapital Advisors LP | 3,861,318 5.100% |
3,861,318 (New Position) |
Filing |